Skip to main content
SpringerLink
Log in

Pressor Agents, Pure Inotropes, Mixed Function Agents

  • Chapter
  • First Online:
Cardiovascular Hemodynamics

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 1844 Accesses

Abstract

Vasoactive pharmacologic agents play an important role in the management of shock. These agents can be broadly categorized as vasodilators, vasopressors, and inotropic agents. Each of these agents can variably affect myocardial preload, afterload, and inotropy to enhance cardiac performance. The choice of these agents is largely dependent on the clinical circumstances faced and a working knowledge of the pharmacologic and hemodynamic effects unique to these agents. This chapter presents the most common vasoactive pharmacologic agents used in clinical practice for the treatment of cardiogenic shock. The hemodynamic as well as pharmacologic properties of these agents are reviewed in order to provide a basis on which a practical understanding of their effects can develop and guide medical decision-making.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tuchschmidt J, Fried J, Astiz M, et al. Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest. 1992;102(1):216–20.

    Article  CAS  Google Scholar 

  2. Felker GM, O’Connor CM. Inotropic therapy for heart failure: an evidence based approach. Am Heart J. 2001;142(3):393–401.

    Article  CAS  Google Scholar 

  3. Taylor RR, Covell JS, Sonnenblick EH, Ross J Jr. Dependence of ventricular distensibility on filling of the opposite ventricle. Am J Phys. 1967;213(3):711–8.

    Article  CAS  Google Scholar 

  4. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316(23):1429–35.

    Article  Google Scholar 

  5. Mullens W, Abrahams Z, Francis GS, et al. Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol. 2008;52(3):200–7.

    Article  CAS  Google Scholar 

  6. Gruppo Italiano per lo Studio della Sopravvivenza nell’infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;343(8906):1115–22.

    Google Scholar 

  7. Flather M, Pipilis A, Collins R, et al. Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects. ISIS-4 (Fourth International Study of Infarct Survival) Pilot Study Investigators. Eur Heart J. 1994;15(5):608–19.

    Article  CAS  Google Scholar 

  8. Opie L, Gersch B, editors. Drugs for the heart. 6th ed. Philadelphia: Elsevier; 2005. p. 161–2.

    Google Scholar 

  9. Dell’Italia LJ, Starling MR, Blumhardt R, et al. Comparative effects of volume loading, dobutamine, and nitroprusside in patients with predominant right ventricular infarction. Circulation. 1985;72(6):1327–35.

    Article  Google Scholar 

  10. Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock. A randomized clinical trial. JAMA. 2013;310(16):1683–91.

    Article  Google Scholar 

  11. Publication committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure. A randomized controlled trial. JAMA. 2002;287(15):1531–40.

    Google Scholar 

  12. Silver MA, Horton DP, Ghali JK, et al. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol. 2002;39(5):798–803.

    Article  CAS  Google Scholar 

  13. O’Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011;365:32–43.

    Article  Google Scholar 

  14. Overgaard CB, Dzavik V. Inotropes and Vasopressors: review of physiology and clinical use in cardiovascular disease. Circulation. 2008;118:1047–56.

    Google Scholar 

  15. Leier CV, Heban PT, Huss P, et al. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation. 1978;58(3 pt 1):466–75.

    Article  CAS  Google Scholar 

  16. Unverferth DV, Magorien RD, Lewis RP, et al. Long-term benefit of dobutamine in patients with congestive cardiomyopathy. Am Heart J. 1980;100(5):622–30.

    Article  CAS  Google Scholar 

  17. Viskin S. Long QT syndromes and torsade de pointes. Lancet. 1999;354(9190):1625–33.

    Article  CAS  Google Scholar 

  18. Cuffe MS, Califf RM, Adams KF Jr, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287(12):1541–7.

    Article  CAS  Google Scholar 

  19. Lowes BD, Tsvetkova T, Eichhorn EJ, et al. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. Int J Cardiol. 2001;81:141–9.

    Article  CAS  Google Scholar 

  20. Kumar A, Choudhary G, Antonio C, et al. Carvedilol titration in patients with congestive heart failure receiving inotropic therapy. Am Heart J. 2001;142:512–5.

    Article  CAS  Google Scholar 

  21. Nieminem MS, Fruhwald S, Heunks LMA, et al. Levosimendan: current data, clinical use and future development. Heart Lung Vessel. 2013;5(4):227–45.

    Google Scholar 

  22. Schumann J, Henrich EC, Strobl H, et al. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low output syndrome. Cochrane Database Syst Rev. 2018:CD009669.pub3. https://doi.org/10.1002/14651858.

  23. Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356(9248):2139–43.

    Article  CAS  Google Scholar 

  24. Marik PE, Iglesias J. Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria. NORA- SEPT II Study Investigators. Am J Med. 1999;107(4):387–90.

    Article  CAS  Google Scholar 

  25. Kellum JA, M Decker J. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med. 2001;29(8):1526–31.

    Article  CAS  Google Scholar 

  26. Bassi G, Radermacher P, Calzia E. Catecholamines and vasopressin during critical illness. Endocrinol Metab Clin N Am. 2006;35(4):839–57.

    Article  CAS  Google Scholar 

  27. Barrett LK, Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med. 2007;35(1):33–40.

    Article  CAS  Google Scholar 

  28. Lindner KH, Dirks B, Strohmenger HU, et al. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet. 1997;349(9051):535–7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gill Heart Institute, University of Kentucky, Lexington, KY, USA

    Paul Anaya & Tracy E. Macaulay

Authors
  1. Paul Anaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tracy E. Macaulay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Anaya .

Editor information

Editors and Affiliations

  1. Premier Health Advocates, Beachwood, OH, USA

    Arman T. Askari

  2. Gill Heart and Vascular Institute, University of Kentucky HealthCare, Lexington, KY, USA

    Adrian W. Messerli

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Anaya, P., Macaulay, T.E. (2019). Pressor Agents, Pure Inotropes, Mixed Function Agents. In: Askari, A., Messerli, A. (eds) Cardiovascular Hemodynamics. Contemporary Cardiology. Humana, Cham. https://doi.org/10.1007/978-3-030-19131-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-19131-3_7

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-19130-6

  • Online ISBN: 978-3-030-19131-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation